Cargando…

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions

Detalles Bibliográficos
Autores principales:	Gonzalez-Cuevas, Gustavo, Garcia-Gutierrez, Maria S, Navarrete, Francisco, de Guglielmo, Giordano, Manzanares, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558431/ https://www.ncbi.nlm.nih.gov/pubmed/34733162 http://dx.doi.org/10.3389/fphar.2021.752292

Ejemplares similares

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD
por: Gasparyan, Ani, et al.
Publicado: (2021)

Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model
por: García-Gutiérrez, María Salud, et al.
Publicado: (2023)

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
por: García-Gutiérrez, María S., et al.
Publicado: (2020)

Mechanisms of manganese-induced neurotoxicity and the pursuit of neurotherapeutic strategies
por: Pajarillo, Edward, et al.
Publicado: (2022)

Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects
por: Rajput, Amarjitsing, et al.
Publicado: (2022)

Editorial: Glaucoma: In Search of Better Neurotherapeutics
por: Russo, Rossella, et al.
Publicado: (2018)

Editorial: The Search for Biomarkers in Psychiatry
por: Garcia-Gutierrez, Maria S., et al.
Publicado: (2021)

Exosome: The “Off-the-Shelf” Cellular Nanocomponent as a Potential Pathogenic Agent, a Disease Biomarker, and Neurotherapeutics
por: Ghosh, Satyajit, et al.
Publicado: (2022)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Mitochondrial Photobiomodulation as a Neurotherapeutic Strategy for Epilepsy
por: Cardoso, Fabrízio dos Santos, et al.
Publicado: (2022)

Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury
por: Martínez-Orgado, José, et al.
Publicado: (2021)

Role of multidrug transporters in neurotherapeutics
por: Jose, Manna, et al.
Publicado: (2009)

Neurotherapeutics for ADHD: Do they work?
por: Rubia, Katya
Publicado: (2022)

Cannabidiol markedly alleviates skin and liver fibrosis
por: del Río, Carmen, et al.
Publicado: (2022)

Editorial: Opioids and opioid-use disorders
por: de Guglielmo, Giordano, et al.
Publicado: (2023)

Updates and advances in multiple sclerosis neurotherapeutics
por: Amin, Moein, et al.
Publicado: (2022)

Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction
por: Song, Chenchen, et al.
Publicado: (2016)

Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023)

Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
por: Scarante, Franciele F., et al.
Publicado: (2021)

Dose-Dependent Antidepressant-Like Effects of Cannabidiol in Aged Rats
por: Hernández-Hernández, Elena, et al.
Publicado: (2022)

Neuroprotective, neurotherapeutic, and neurometabolic effects of carbon monoxide
por: Mahan, Vicki L
Publicado: (2012)

The social neuroscience of psychosis: From neurobiology to neurotherapeutics
por: Mehta, Urvakhsh Meherwan
Publicado: (2020)

Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats
por: Ceprián, María, et al.
Publicado: (2019)

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
por: Cassano, Tommaso, et al.
Publicado: (2020)

Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders
por: Jurkus, Regimantas, et al.
Publicado: (2016)

A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
por: Millar, Sophie A., et al.
Publicado: (2018)

Cannabidiol Reduces Leukemic Cell Size – But Is It Important?
por: Kalenderoglou, Nikoletta, et al.
Publicado: (2017)

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
por: Montoya, Zackary, et al.
Publicado: (2020)

Cannabidiol for neurodegenerative disorders: A comprehensive review
por: Bhunia, Sukanya, et al.
Publicado: (2022)

Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic
por: Souza, José Diogo S., et al.
Publicado: (2022)

Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
por: Campos, Alline C., et al.
Publicado: (2017)

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
por: Morales, Paula, et al.
Publicado: (2017)

Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
por: Pauli, Christopher S., et al.
Publicado: (2020)

A Balanced Approach for Cannabidiol Use in Chronic Pain
por: Argueta, Donovan A., et al.
Publicado: (2020)

Anti-oxidant effects of cannabidiol relevant to intracerebral hemorrhage
por: Yan, Gaili, et al.
Publicado: (2023)

Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
por: Crippa, José A. S., et al.
Publicado: (2016)

CB2 Receptor Involvement in the Treatment of Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

Molecular Mechanisms of Astaxanthin as a Potential Neurotherapeutic Agent
por: Bahbah, Eshak I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t5sc7eubuu45ssjm9ooot4np9f